Literature DB >> 19463803

Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay.

Sieglinde Zelzer1, Gholamali Khoschsorur, Mariana Stettin, Gisela Weihrauch, Martini Truschnig-Wilders.   

Abstract

BACKGROUND: The increased demand in clinical chemistry laboratories for determination of myeloperoxidase (MPO) as a potential marker for cardiovascular diseases has led to the development of several analytical methods, especially enzyme-linked immunosorbent assay (ELISA, e. g. from Immundiagnostik AG), and recently a new chemiluminescent automated immunoassay (CMIA, Architect MPO assay, Abbott Diagnostics).
METHODS: We compared data from 115 patients obtained from an ELISA reference method (Immundiagnostik AG) with data obtained from the automated Architect MPO assay.
RESULTS: The new MPO assay from Abbott Diagnostics correlates well with the ELISA (y=0.767x+7.035; R(2)=0.9204). The difference plot according to Bland-Altman analysis shows a mean bias of -1.048 microg/l, with a probability of 95%.
CONCLUSIONS: The Architect MPO assay can easily be adapted to the Architect instrument system and it is advantageous as far as technology and analysis time are concerned. This new automated MPO assay shows excellent analytical performance and provides a precise and convenient automated method for the measurement of MPO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463803     DOI: 10.1016/j.cca.2009.05.009

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  Emerging inflammatory markers for assessing coronary heart disease risk.

Authors:  Marshall A Corson
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

2.  Amperometric sandwich immunoassay for determination of myeloperoxidase by using gold nanoparticles encapsulated in graphitized mesoporous carbon.

Authors:  Bei Liu; Lingsong Lu
Journal:  Mikrochim Acta       Date:  2019-03-30       Impact factor: 5.833

3.  Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.

Authors:  W H Wilson Tang; Yuping Wu; Stephen J Nicholls; Stanley L Hazen
Journal:  Clin Chem       Date:  2010-11-08       Impact factor: 8.327

4.  Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters.

Authors:  Aderville Cabassi; Simone Maurizio Binno; Stefano Tedeschi; Gallia Graiani; Cinzia Galizia; Michele Bianconcini; Pietro Coghi; Federica Fellini; Livia Ruffini; Paolo Govoni; Massimo Piepoli; Stefano Perlini; Giuseppe Regolisti; Enrico Fiaccadori
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.